Collectively, these results suggested that a history of prior infection with SARS-CoV-2, but not vaccination, significantly enhanced rapid and efficient nasal anti-spike S-IgA responses that shortened the duration of infectious virus shedding. The gene discussed is CD79A; the disease is infection.